Transthyretin Kinetic Stabilizers for ATTR Amyloidosis

Bibliographic Details
Published in:	Cardiology and Therapy
Main Author:	Jeffery W. Kelly
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-07-01
Online Access:	https://doi.org/10.1007/s40119-025-00422-8

Similar Items

Transthyretin Kinetic Stabilizers for ATTR Amyloidosis: A Narrative Review of Mechanisms and Therapeutic Benefits
by: Evan T. Powers, et al.
Published: (2025-07-01)

Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review
by: Diego Delgado, et al.
Published: (2025-01-01)

Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)
by: Sergey N. Tereshchenko, et al.
Published: (2022-05-01)

Inotersen to Treat Polyneuropathy Associated with Hereditary Transthyretin (hATTR) Amyloidosis
by: Christopher Robinson, et al.
Published: (2023-01-01)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
by: Dulce Brito (Chair), et al.
Published: (2023-10-01)

Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review
by: Emre Aldinc, et al.
Published: (2023-09-01)

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
by: Maximilian Steinebrei, et al.
Published: (2023-11-01)

Reliability and validity of the Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire impact scales
by: Andrew Lovley, et al.
Published: (2025-04-01)

Monitoring patients and asymptomatic carriers with hereditary transthyretin amyloidosis: regional protocol of Emilia-Romagna ATTR working group
by: Pietro Guaraldi, et al.
Published: (2025-08-01)

Efficacy and safety of diflunisal therapy in patients with transthyretin cardiac amyloidosis (ATTR-CA): a systematic review and meta-analysis
by: Wilbert Huang, et al.
Published: (2025-03-01)

ATTR Variant Amyloidosis in Patients with Dysphagia
by: Christina Hui Lee Ng, et al.
Published: (2023-06-01)

Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease
by: Per M. Roos, et al.
Published: (2024-06-01)

Unusual presentation of transthyretin (ATTR) cardiac amyloidosis: A case report of pruritus as a possible initial symptom and challenging diagnosis
by: Massood Baghaee, et al.
Published: (2023-09-01)

Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis
by: John L. Berk, MD, et al.
Published: (2025-08-01)

The Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure
by: O'Connor M, et al.
Published: (2023-07-01)

A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
by: Teresa Coelho, et al.
Published: (2020-07-01)

Vutrisiran in Transthyretin Amyloidosis
by: Ronald M. Witteles, MD, et al.
Published: (2025-09-01)

Management of transthyretin amyloidosis
by: Adalgisa Condoluci, et al.
Published: (2021-10-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024-07-01)

Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage
by: V. V. Rameev, et al.
Published: (2019-07-01)

Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm
by: Jessica Ammon, et al.
Published: (2024-11-01)

Dynamic changes of intracellular signals in ATTR Tyr114Cys amyloidosis
by: Kenta Ouchi, et al.
Published: (2025-06-01)

Long Term Prognostic Significance of CMR and Echocardiographic Parameters in ATTR Amyloidosis
by: Joseph Justin Regalado, MD, et al.
Published: (2024-01-01)

Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report
by: Filipp I. Orlov, et al.
Published: (2023-11-01)

Advances in the treatment of transthyretin amyloidosis
by: Intissar Anan
Published: (2025-07-01)

Erratum to: Management of transthyretin amyloidosis
by: Swiss Medical Weekly
Published: (2021-11-01)

Co‐Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination
by: Arnaud Planchat, et al.
Published: (2025-10-01)

Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy
by: Binh An Nguyen, et al.
Published: (2024-01-01)

Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
by: Luca Gentile, et al.
Published: (2021-04-01)

Microvascular Obstruction in AL and ATTR Cardiac Amyloidosis: Prevalence, Characterisation and Prognostic Implication
by: Lucrezia Netti, MD, et al.
Published: (2024-01-01)

Deep Learning to Classify AL versus ATTR Cardiac Amyloidosis MR Images
by: Philippe Germain, et al.
Published: (2023-01-01)

Patient with ATTR cardiac amyloidosis presenting with heart failure with reduced ejection fraction
by: Jay Gohri, et al.
Published: (2024-01-01)

Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care
by: Julian D. Gillmore, et al.
Published: (2025-03-01)

Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report
by: Daria P. Golubovskaya, et al.
Published: (2024-07-01)

Kidney, the Cinderella Story of Transthyretin Amyloidosis
by: Nelson Leung
Published: (2025-06-01)

Specific therapeutic options for transthyretin amyloidosis
by: Zoltán Pozsonyi
Published: (2024-12-01)

A review of transthyretin cardiac amyloidosis
by: Jhawar Nikita, et al.
Published: (2023-03-01)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
by: Douglas J. Leedy, et al.
Published: (2023-08-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)